Literature DB >> 12832172

General Surgeons and trauma. A questionnaire survey of General Surgeons training in ATLS and involvement in the trauma team.

Adam Brooks1, James Williams, William Butcher, James Ryan.   

Abstract

OBJECTIVE: To determine the level of training of General Surgeons in the UK in the Advanced Trauma Life Support (ATLS) course and their involvement with hospital trauma teams.
METHODS: Postal questionnaire sent to General Surgical Consultants and Higher Surgical Trainees (HSTs).
RESULTS: 58% of General Surgeons who responded had attended ATLS, but only 30% of those who had been Consultants for more than 10 years. Eighty-seven percent considered the course 'essential' or 'some value'. Sixty-one percent of hospitals represented had a trauma team. A Consultant General Surgeon was a member of the team in 50% and the General Surgical HST in 82%.
CONCLUSION: ATLS has been widely accepted by General Surgical Trainees and recently appointed Consultants. The trauma team approach to resuscitation has yet to become fully established in the UK and there is limited input from Consultant General Surgeons.

Entities:  

Mesh:

Year:  2003        PMID: 12832172     DOI: 10.1016/s0020-1383(02)00413-8

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  3 in total

Review 1.  The Advanced Trauma Life Support course: a history of its development and review of related literature.

Authors:  M R Carmont
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

2.  [Interdisciplinary emergency room management of trauma patients from the standpoint of coworkers].

Authors:  T Gross; F Amsler; W Ummenhofer; M Zuercher; P Regazzoni; A L Jacob; R W Huegli; P Messmer
Journal:  Chirurg       Date:  2005-10       Impact factor: 0.955

3.  Military general surgical training opportunities on operations in Afghanistan.

Authors:  Adam J Brooks; Arul Ramasamy; David Hinsley; Mark Midwinter
Journal:  Ann R Coll Surg Engl       Date:  2009-07       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.